These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24467433)

  • 1. An update on zolpidem abuse and dependence.
    Victorri-Vigneau C; Gérardin M; Rousselet M; Guerlais M; Grall-Bronnec M; Jolliet P
    J Addict Dis; 2014; 33(1):15-23. PubMed ID: 24467433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey.
    Victorri-Vigneau C; Dailly E; Veyrac G; Jolliet P
    Br J Clin Pharmacol; 2007 Aug; 64(2):198-209. PubMed ID: 17324242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zolpidem at supratherapeutic doses can cause drug abuse, dependence and withdrawal seizure.
    Sethi PK; Khandelwal DC
    J Assoc Physicians India; 2005 Feb; 53():139-40. PubMed ID: 15847035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The French addictovigilance network clinical assessment: Z-drugs, true false twins.
    Rousselet M; Feuillet F; Gerardin M; Jolliet P; Hardouin JB; Victorri-Vigneau C
    Expert Opin Drug Saf; 2017 Sep; 16(9):1063-1069. PubMed ID: 28649864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological evidence for a low abuse potential of zolpidem.
    Soyka M; Bottlender R; Möller HJ
    Pharmacopsychiatry; 2000 Jul; 33(4):138-41. PubMed ID: 10958262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. French national health insurance database analysis and field study focusing on the impact of secure prescription pads on zolpidem consumption and sedative drug misuse: ZORRO study protocol.
    Gérardin M; Rousselet M; Caillet P; Grall-Bronnec M; Loué P; Jolliet P; Victorri-Vigneau C
    BMJ Open; 2019 Jun; 9(6):e027443. PubMed ID: 31256026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zolpidem abuse.
    Madrak LN; Rosenberg M
    Am J Psychiatry; 2001 Aug; 158(8):1330-1. PubMed ID: 11481176
    [No Abstract]   [Full Text] [Related]  

  • 8. Slow-release oral morphine sulfate abuse: results of the postmarketing surveillance systems for psychoactive prescription drug abuse in France.
    Peyriere H; Eiden C; Micallef J; Lapeyre-Mestre M; Faillie JL; Blayac JP
    Eur Addict Res; 2013; 19(5):235-44. PubMed ID: 23428846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zolpidem dependence case series: possible neurobiological mechanisms and clinical management.
    Liappas IA; Malitas PN; Dimopoulos NP; Gitsa OE; Liappas AI; Nikolaou ChK; Christodoulou GN
    J Psychopharmacol; 2003 Mar; 17(1):131-5. PubMed ID: 12680751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypnotic dependence: zolpidem and zopiclone too.
    Prescrire Int; 2001 Feb; 10(51):15. PubMed ID: 11503851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous zolpidem injection in a zolpidem abuser.
    Hsu WY; Chiu NY
    Pharmacopsychiatry; 2013 May; 46(3):121-2. PubMed ID: 23093474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zolpidem tolerance and dependence--two case reports.
    Ravishankar A; Carnwath T
    J Psychopharmacol; 1998; 12(1):103-4. PubMed ID: 9584975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zolpidem dependence and withdrawal seizure--report of two cases.
    Wang LJ; Ree SC; Chu CL; Juang YY
    Psychiatr Danub; 2011 Mar; 23(1):76-8. PubMed ID: 21448102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change.
    Aquizerate A; Laforgue EJ; Istvan M; Rousselet M; Gerardin M; Jouanjus E; Libert F; ; Guerlais M; Victorri-Vigneau C
    Eur J Public Health; 2023 Apr; 33(2):169-175. PubMed ID: 36749030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregabalin in zolpidem dependence and withdrawal.
    Oulis P; Nakkas G; Masdrakis VG
    Clin Neuropharmacol; 2011; 34(2):90-1. PubMed ID: 21407000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zolpidem dependence. Zolpidem dependence is frequent, and should be discussed with patients.
    Prescrire Int; 2008 Jun; 17(95):114. PubMed ID: 18634166
    [No Abstract]   [Full Text] [Related]  

  • 17. [Zolpidem dependence and depression in the elderly].
    Thome J; Ruchsow M; Rösler M; Becker T
    Psychiatr Prax; 1995 Jul; 22(4):165-6. PubMed ID: 7675909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependence and tolerance with zolpidem.
    Sánchez LG; Sanchez JM; Lopez Moreno J
    Am J Health Syst Pharm; 1996 Nov; 53(21):2638. PubMed ID: 8913396
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study.
    Schoedel KA; Sun H; Sellers EM; Faulknor J; Levy-Cooperman N; Li X; Kennedy WP; Cha JH; Lewis NM; Liu W; Bondiskey P; McCrea JB; Panebianco DL; Troyer MD; Wagner JA
    J Clin Psychopharmacol; 2016 Aug; 36(4):314-23. PubMed ID: 27253658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of parenteral zolpidem dependence with opioid-like withdrawal symptoms.
    Kao CL; Huang SC; Yang YJ; Tsai SJ
    J Clin Psychiatry; 2004 Sep; 65(9):1287. PubMed ID: 15367062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.